Chemical Works of Gedeon Richter Plc. was founded in 1901 and is based in Budapest, Hungary, specializing in the development and manufacture of pharmaceuticals and active pharmaceutical ingredients. The company is recognized for its innovative products in the fields of women's health, central nervous system disorders, and bacteriological products.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| RICHT 1.75% 2031-06-04 HUFChemical Works of Gedeon Richter Plc. | Hungary | 2031-06-04 | 1.750 | 9.21 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Chemical Works of Gedeon Richter has been a proactive participant in bond markets, beginning its bond issuance strategy in the early 1990s. The company has issued significant bonds throughout its history, including a notable €300 million bond in 2019, which was well-received and highlighted its strong market position. As of October 2023, its current bonds yield around 3.5%, competitive within the pharmaceutical sector, offering investors attractive opportunities with features such as callable options. Recent news includes plans for further issuances to fund ongoing R&D efforts.